In a recent effort to scale up the manufacturing of platelets using iPS cell-derived megakaryocytes, Professor Koji Eto (Department of Clinical Application) and his team of researchers, through computational simulation and biological testing, conceived new design changes for an impeller-based bioreactor for large-scale, high-quality platelet production. The study is published in Communications Engineering.
Refining turbulent flow to scale up iPS cell-based platelet manufacturing
